Results

Expected Results

This project will provide information for a range of audiences as follows:

  • the EC decision makers and EMCDDA, who require concise, objective information in order to make the relevant policy decisions.
  • Scientists and other professionals working in the drugs field can use this information source on ongoing research activities and also as a link for cross-border cooperation, hence enhancing data collection practices across Europe
  • As an audience, the general public needs broad information in order to gain insight into changes in the drug situation and responses at national and European level
  • For the media, information on the drug situation, not only in the country concerned, but also in Europe. The information provided to the media thus facilitates clear and factual reporting on the drugs situation.
  • EMCDDA, who will receive complementary information with data from EWS.
  • Young researchers and students. Collaboration in training and research already exists between partners as a result of ongoing European projects and activities have resulted in significant benefits, such as exchange visits, training and increased exposure, for many young researchers. This research training capacity in Europe will be further extended within this project.

The project intends to develop an integrated approach to improve the capacity to identify and assess the NPS mostly spreading in Europe, and to estimate their extent and pattern of use in Europe. This will provide knowledge useful to EMCDDA and EC to regulate these substances within EU and to develop best practice on prevention in specific groups of potential consumers. This approach has the potential to identify and rank NPS according to their diffusion, improving the knowledge on their extent of use and risks for health and society, and this will allow EMCDDA and EC to optimize interventions focusing their activities of regulation and contrast to the most diffused and toxic NPS in Europe. With this improvement in knowledge, prevention measures can be targeted in a more precise way.

The project will also investigate consumer behaviour and perception and pattern of use of these substances, thus promoting awareness in consumers and providing information useful to set up effective practice of prevention. It will be established whether and how NPS users differ from users of traditional drugs and thus whether prevention measures have to be designed differently for NPS users, thus improving the basis for practices of prevention.

Priority of the call is to support the implementation of EU legislation on NPS by improving the capacity to identify and assess these substances, to respond to their spread across the EU, by reducing the availability of harmful substances, monitoring the extent and patterns of use of such substances and by sharing best practices on prevention. Objective of this project is to improve NPS identification, to assess their risks, and to estimate their extent and pattern of use. The information will be delivered to EMCDDA, NFP and EC, with the aim to support the implementation of EU legislation on NPS, contributing to effective actions to reduce the availability of harmful NPS in Europe and to develop best practice on prevention.